Curelo, a diagnostic-guided healthcare platform focused on improving consumer healthcare decisions, has announced the expansion of its leadership team.

Dr. Amit Arora has been appointed as Co-founder & COO, leading Curelo’s logistics, operations, and execution strategy.

Previously, Dr Arora co-founded Labforsure (later Droplet), India’s first third-party phlebotomy platform, which expanded into a nationwide home sample collection network across more than 50 cities before being acquired by 1mg. He also founded Rapidx Pathology Labs, scaling it to 1 lakh orders per month across North India before its acquisition by Orange Health.

The expanded leadership team now includes Dr. Amit Arora as Co-founder & COO, Aniruddha Kannal as Chief Product & Technology Officer (CPTO), and Abhinay Singh as Director-Growth & Digital. They join Founder Dr. Arpit Jayswal and Co-founder & CMO Parth Jaiswal in driving Curelo’s expansion across diagnostics, AI-powered health guidance, and digital healthcare engagement services.

Dr. Arpit Jayswal, Founder, Curelo, said, “This new addition to our executive board takes place at a crucial point in our organization’s development when we are focusing heavily on leveraging technology and AI-guided preventive health experiences as well as infrastructural capabilities.”

Dr. Amit Arora, Co-founder & COO, Curelo said, “Curelo’s vision of building a technology-led and consumer-centric healthcare platform strongly aligns with the future direction of diagnostics in India. Our focus will be on creating scalable systems that improve accessibility, reliability, and overall consumer experience.”

Founded in 2022, Curelo currently works with over 1,500 partner labs, offers access to more than 3,000 diagnostic tests and wellness packages, and has served over 3.5 lakh consumers across India.